Regulations.gov document
Prescription Drug User Fee Act VII; Independent Assessment of Communication Through…
Notice · FDA-2022-N-2335 · posted Oct 14, 2022
Key facts
| Document ID | FDA-2022-N-2335-0001 |
|---|---|
| Title | Prescription Drug User Fee Act VII; Independent Assessment of Communication Through Product Quality Information Requests During Application Review; Statement of Work; Request for Comments |
| Document type | Notice |
| Subtype | Request for Comments |
| Agency | FDA |
| Docket | FDA-2022-N-2335 |
| Posted | Oct 14, 2022 |
| Federal Register citation | 87 FR 62419 |
| FR document number | 2022-22335 |
| Comment period opens | Oct 14, 2022 |
| Comments due | Nov 15, 2022 |
| Effective date | Oct 14, 2022 |
At a glance
- 1–9 Pages
- No Open for comment
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: